NOW ENROLLING
Phase 3 Study of Cabozantinib With Atezolizumab vs Second Novel Hormonal Therapy in mCRPC
The combination of cabozantinib and atezolizumab is not
approved for the use under investigation in this trial.
Safety and efficacy have not been established.